Cargando…
Blood collection in cell-stabilizing tubes does not impact germline DNA quality for pediatric patients
OBJECTIVES: Liquid biopsy technologies allow non-invasive tumor profiling for patients with solid tumor malignancies by sequencing circulating tumor DNA. These studies may be useful in risk-stratification, monitoring for relapse, and understanding tumor evolution. The quality of DNA obtained for the...
Autores principales: | Wollison, Bruce M., Thai, Edwin, Mckinney, Aimee, Ward, Abigail, Clapp, Andrea, Clinton, Catherine, Nag, Anwesha, Thorner, Aaron R., Gastier-Foster, Julie M., Crompton, Brian D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716571/ https://www.ncbi.nlm.nih.gov/pubmed/29206863 http://dx.doi.org/10.1371/journal.pone.0188835 |
Ejemplares similares
-
Genomic Evolution in a Patient With Lung Adenocarcinoma With a Germline EGFR T790M Mutation
por: Mäkinen, Netta, et al.
Publicado: (2021) -
Circulating Tumor DNA Is Associated with Response and Survival in Patients with Advanced Leiomyosarcoma
por: Madanat-Harjuoja, Laura M., et al.
Publicado: (2022) -
Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533
por: Madanat-Harjuoja, Laura M., et al.
Publicado: (2022) -
Adverse prognostic impact of the loss of STAG2 protein expression in patients with newly diagnosed localised Ewing sarcoma: A report from the Children’s Oncology Group
por: Shulman, David S., et al.
Publicado: (2022) -
Detection of circulating tumour DNA is associated with
inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s
Oncology Group
por: Shulman, David S., et al.
Publicado: (2018)